These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8343967)
1. Low-dose streptozotocin-induced diabetes in mice. I. Course of Candida albicans infection. Mosci P; Vecchiarelli A; Cenci E; Puliti M; Bistoni F Cell Immunol; 1993 Aug; 150(1):27-35. PubMed ID: 8343967 [TBL] [Abstract][Full Text] [Related]
2. Low-dose streptozotocin-induced diabetes in mice. II. Susceptibility to Candida albicans infection correlates with the induction of a biased Th2-like antifungal response. Mencacci A; Romani L; Mosci P; Cenci E; Tonnetti L; Vecchiarelli A; Bistoni F Cell Immunol; 1993 Aug; 150(1):36-44. PubMed ID: 8102088 [TBL] [Abstract][Full Text] [Related]
3. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Vecchiarelli A; Cenci E; Puliti M; Blasi E; Puccetti P; Cassone A; Bistoni F Cell Immunol; 1989 Dec; 124(2):334-44. PubMed ID: 2510940 [TBL] [Abstract][Full Text] [Related]
4. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein. Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606 [TBL] [Abstract][Full Text] [Related]
6. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. Romani L; Puccetti P; Mencacci A; Cenci E; Spaccapelo R; Tonnetti L; Grohmann U; Bistoni F J Immunol; 1994 Apr; 152(7):3514-21. PubMed ID: 7908304 [TBL] [Abstract][Full Text] [Related]
7. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F Infect Immun; 1989 Nov; 57(11):3581-7. PubMed ID: 2572556 [TBL] [Abstract][Full Text] [Related]
8. Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus. Venturini J; Fraga-Silva TF; Marchetti CM; Mimura LA; Conti BJ; Golim Mde A; Mendes RP; de Arruda MS Immunol Invest; 2016 Jul; 45(5):420-38. PubMed ID: 27105208 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection. Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189 [TBL] [Abstract][Full Text] [Related]
10. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice. Khan MA; Aldebasi YH; Alsuhaibani SA; AlSahli MA; Alzohairy MA; Khan A; Younus H PLoS One; 2018; 13(12):e0208951. PubMed ID: 30589842 [TBL] [Abstract][Full Text] [Related]
12. Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. Algarra I; Ortega E; Serrano MJ; Alvarez de Cienfuegos G; Gaforio JJ FEMS Immunol Med Microbiol; 2002 Jul; 33(3):159-63. PubMed ID: 12110477 [TBL] [Abstract][Full Text] [Related]
13. Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha. Vecchiarelli A; Todisco T; Puliti M; Dottorini M; Bistoni F Am J Respir Cell Mol Biol; 1989 Jul; 1(1):49-55. PubMed ID: 2516451 [TBL] [Abstract][Full Text] [Related]
14. The importance of the phagocytes' innate response in resolution of the infection induced by a low virulent Candida albicans mutant. Molero G; Guillén MV; Martínez-Solano L; Gil C; Pla J; Nombela C; Sánchez-Pérez M; Diez-Orejas R Scand J Immunol; 2005 Sep; 62(3):224-33. PubMed ID: 16179009 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone. Kobayashi-Sakamoto M; Tamai R; Isogai E; Kiyoura Y Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742 [TBL] [Abstract][Full Text] [Related]
16. Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans. Hu Y; Farah CS; Ashman RB Immunol Cell Biol; 2006 Oct; 84(5):455-60. PubMed ID: 16869942 [TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052 [TBL] [Abstract][Full Text] [Related]
18. Infection and tissue repair of experimental cutaneous candidiasis in diabetic mice. Pupim ACE; Campois TG; Araújo EJA; Svidizinski TIE; Felipe I J Med Microbiol; 2017 Jun; 66(6):808-815. PubMed ID: 28604330 [TBL] [Abstract][Full Text] [Related]
19. CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide. Netea MG; Meer JW; Verschueren I; Kullberg BJ Eur J Immunol; 2002 May; 32(5):1455-63. PubMed ID: 11981834 [TBL] [Abstract][Full Text] [Related]
20. The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. Lavigne LM; Schopf LR; Chung CL; Maylor R; Sypek JP J Immunol; 1998 Jan; 160(1):284-92. PubMed ID: 9551982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]